BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23775380)

  • 1. Big enough for an aromatase inhibitor? How adiposity affects male fertility.
    Stephens SM; Polotsky AJ
    Semin Reprod Med; 2013 Jul; 31(4):251-7. PubMed ID: 23775380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios.
    Gregoriou O; Bakas P; Grigoriadis C; Creatsa M; Hassiakos D; Creatsas G
    Fertil Steril; 2012 Jul; 98(1):48-51. PubMed ID: 22579129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase inhibitors for male infertility.
    Schlegel PN
    Fertil Steril; 2012 Dec; 98(6):1359-62. PubMed ID: 23103016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of aromatase inhibitor letrozole in NOA with an elevated FSH level: a case report.
    Zhao D; Pan L; Zhang F; Pan F; Ma J; Zhang X; Liu Y
    Andrologia; 2014 May; 46(4):456-7. PubMed ID: 23803162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibitors for male infertility.
    Raman JD; Schlegel PN
    J Urol; 2002 Feb; 167(2 Pt 1):624-9. PubMed ID: 11792932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of male infertility secondary to morbid obesity.
    Roth MY; Amory JK; Page ST
    Nat Clin Pract Endocrinol Metab; 2008 Jul; 4(7):415-9. PubMed ID: 18523426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome.
    Casper RF; Mitwally MF
    Clin Obstet Gynecol; 2011 Dec; 54(4):685-95. PubMed ID: 22031258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
    Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
    Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of aromatase inhibitor letrozole on body mass index, serum hormones, and sperm parameters in infertile men.
    Saylam B; Efesoy O; Cayan S
    Fertil Steril; 2011 Feb; 95(2):809-11. PubMed ID: 20934689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of letrozole on spermogram parameters and hormonal profile in infertile men: A clinical trial study.
    Peivandi S; Jafarpour H; Abbaspour M; Ebadi A
    Endocr Regul; 2019 Oct; 53(4):231-236. PubMed ID: 31734656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and male infertility: a practical approach.
    Hammoud AO; Meikle AW; Reis LO; Gibson M; Peterson CM; Carrell DT
    Semin Reprod Med; 2012 Dec; 30(6):486-95. PubMed ID: 23074007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism.
    de Boer H; Verschoor L; Ruinemans-Koerts J; Jansen M
    Diabetes Obes Metab; 2005 May; 7(3):211-5. PubMed ID: 15811136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
    Monnier AM
    Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index-associated differences in response to ovulation induction with letrozole.
    McKnight KK; Nodler JL; Cooper JJ; Chapman VR; Cliver SP; Bates GW
    Fertil Steril; 2011 Nov; 96(5):1206-8. PubMed ID: 21867999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility.
    Del Giudice F; Busetto GM; De Berardinis E; Sperduti I; Ferro M; Maggi M; Gross MS; Sciarra A; Eisenberg ML
    Asian J Androl; 2020; 22(4):360-367. PubMed ID: 31621654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply of the Authors: Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole.
    Naelitz BD; Lundy SD; Nowacki AS
    Fertil Steril; 2024 Jul; 122(1):190. PubMed ID: 38616033
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary on "Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole".
    Li D; Zeng X
    Fertil Steril; 2024 Jul; 122(1):189. PubMed ID: 38494104
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.
    Bedaiwy MA; Forman R; Mousa NA; Al Inany HG; Casper RF
    Hum Reprod; 2006 Nov; 21(11):2838-44. PubMed ID: 16877370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer.
    Zabolotny BP; Zalai CV; Meterissian SH
    J Surg Oncol; 2005 Apr; 90(1):26-30. PubMed ID: 15786432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial.
    Kamath MS; Aleyamma TK; Chandy A; George K
    Fertil Steril; 2010 Dec; 94(7):2857-9. PubMed ID: 20638059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.